Detection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital

FEMS Immunology and Medical Microbiology

Volumn 56, Issue 3, 2009, Pages 191-196

  Ehlers, Marthie M ^a   Veldsman, Chrisna ^a   Makgotlho, Eddy P ^a   Dove, Michael G ^a   Hoosen, Anwar A ^a   Kock, Marleen M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Cefotaximase; Extended spectrum lactamases; Sulfhydryl variable; Temoniera

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM ISOLATE; BLA CTX M GENE; BLA SHV GENE; BLA TEM GENE; CITROBACTER FREUNDII; CONTROLLED STUDY; DENMARK; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; EUROPE; GENE AMPLIFICATION; GENE IDENTIFICATION; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEUS PENNERI; SHORT SURVEY; UNIVERSITY HOSPITAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; REVIEW; SOUTH AFRICA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS; HUMANS; SOUTH AFRICA;

EID: 67650739261     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00564.x     Document Type: Short Survey

References (24)

1. Al-Jasser AM (2006) Extended-spectrum β-lactamases (ESBLs) A global problem. KMJ 38 : 171 185.
2. Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ Jones RN (2007) Prevalence and significance of a negative extended-spectrum β-lactamases (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific surveillance program. J Clin Microbiol 45 : 1478 1482. (Pubitemid 46762401)
3. Colodner R (2005) Extended-spectrum β-lactamases: a challenge for clinical microbiologists and infection control specialists. Am J Infect Control 33 : 104 107. (Pubitemid 40283472)
4. Eisner A, Fagan EJ, Feierl G, Kessler HH, Marth E, Livermore DM Woodford N (2006) Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria. Antimicrob Agents Ch 50 : 785 787. (Pubitemid 43191002)
5. Kim S, Hu J, Gautom R, Kim J, Lee B Boyle DS (2007) CTX-M extended-spectrum β-lactamases, Washington State. Emerg Infect Dis 13 : 513 514. (Pubitemid 46348155)
6. Lewis JS II., Herrera M, Wickes B, Patterson JE Jorgensen JH (2007) First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System. Antimicrob Agents Ch 51 : 4015 4021. (Pubitemid 350057800)
7. Meyer L, Labuschagne CDJ, Ehlers MM, Dove MG Weldhagen CF (2004) Diversity of bla-type genes in extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated during 2003-2004 at Pretoria Academic Hospital. S Afr J Epid Infect 22 : 5 7.
8. Meyer L, Labuschagne CDJ, Ehlers MM, Dove MG Weldhagen GF (2007) Diversity of bla-type genes in extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated during 2003-2004 at Pretoria Academic Hospital. SAJEI 22 : 5 7.
9. CTX-M genes in Enterobacteriaceae. APMIS 115 : 1400 1408.
10. Naseer U, Natås OB, Haldorsen BC, Bue B, Grundt H, Walsh TR Sundsfjort A (2006) Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. APMIS 114 : 120 126.
11. Paterson DL (2000) Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Euro Soc Clin Micro Infect Dis 6 : 460 463. (Pubitemid 34966064)
12. Perez F, Endimiani A, Hujer KM Bonomo RA (2007) The continuing challenge of ESBLs. Curr Opin Pharmacol 7 : 459 469. (Pubitemid 47560222)
13. Pitout JDD Laupland KB (2008) Extended-spectrum β-lactamase producing Enterobacteriaecae: an emerging public health. Microbiol Infect Dis 8 : 159 166. (Pubitemid 351249250)
14. Pitout JDD, Nordmann P, Laupland KB Poirel L (2005) Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemoth 10 : 1 8.
15. Pitout JDD, Hamilton N, Church DL, Nordmann P Poirel L (2006) Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type β-lactamase in Enterobacteriaceae. Clin Microbiol Infec 13 : 291 297. (Pubitemid 46603360)
16. Pitout JDD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR Laupland KB (2007) Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15 producing isolates. Antimicrob Agents Ch 51 : 1281 1286. (Pubitemid 46586806)
17. Rodríquez-Baño J, Navarro MD, Romero L, Muniain MA, Perea EJ, Pérez-Cano R, Hernández JR Pascual A (2006) Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 42 : 37 45. (Pubitemid 41832077)
18. Romero EDV, Padilla TP, Hernández AH, Grande RP, Vázques MF, García IG, García-Rodríquez JA Bellido JLM (2007) Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases. Diagn Micr Infec Dis 59 : 433 437. (Pubitemid 350184221)
19. Samaha-Kfoury JN Araj GF (2003) Recent developments in β-lactamases and extended spectrum β-lactamases. BMJ 327 : 1209 1213. (Pubitemid 37465208)
20. Sorlózano A, Gutiérrez J, Palanca M, Soto MJ Piédrola G (2004) High incidence of extended-spectrum β-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method. Diagn Micr Infec Dis 50 : 131 134. (Pubitemid 39335849)
21. Stürenburg E Mack D (2003) Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy and infection control. Infection 47 : 273 295. (Pubitemid 37322047)
22. Tzouvelekis LS, Tzelepi E, Tassions PT Legakis NJ (2000) CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Ag 14 : 137 142. (Pubitemid 30138181)
23. Winkokur PL, Canton R, Casellas JM Legakis N (2001) Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterisation of isolates from Europe, the Americas and the Western Pacific region. Clin Infect Dis 32 : 94 103.
24. Woodford N, Ward ME, Kaufmann ME et al 2004) Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemoth 54 : 735 743. (Pubitemid 39386725)